Search for: "VALEANT PHARMACEUTICALS INTERNATIONAL"
Results 21 - 40
of 51
Sort by Relevance
|
Sort by Date
2 Feb 2018, 4:00 am
Valeant Pharmaceuticals International Inc. [read post]
17 Jan 2018, 5:58 am
Valeant Pharmaceuticals International, Inc., January 12, 2018, Shipp, M.).The complaints are direct actions under Sections 10(b), 18(a), and 20(a) of the Exchange Act, not to be confused with the class action pending before the same court and arising out of the same facts and circumstances. [read post]
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
8 Feb 2017, 5:45 am
Allergan Inc. has agreed with the SEC that it will admit to securities law violations and will pay a $15 million fine for disclosure violations in its Schedule 14D-9 relating to the unsolicited, public takeover bid for the company made by Valeant Pharmaceuticals International in 2014. [read post]
16 Nov 2016, 8:56 am
Agency Enforcement FTC Requires Valeant to Divest Recently Acquired Paragon Valeant Pharmaceuticals International, Inc., parent company of Bausch+Lomb, has agreed to divest Paragon Holdings, which it acquired in May 2015, to settle charges that the acquisition violated the Clayton Act and the FTC Act. [read post]
8 Aug 2016, 5:11 pm
The two companies are Valeant Pharmaceuticals and LendingClub. [read post]
26 May 2016, 7:42 am
Nelson, J.D.Valeant Pharmaceuticals International, Inc. [read post]
1 Apr 2016, 6:00 am
Valeant may get bank waivers but risks default with SEC and NYSE by Francine McKenna in MarketWatch Valeant Pharmaceuticals International Inc. may get a waiver from its bank lenders to file its Form 10-K annual report and first-quarter report later than required. [read post]
31 Mar 2016, 7:02 am
Elijah Cummings (D-MD) released two memos detailing key findings from over 250,000 pages of documents provided to the House Oversight and Government Reform Committee by Turing Pharmaceuticals and another 75,000 by Valeant. [read post]
7 Nov 2015, 2:36 pm
The United States Attorney’s Office for the Eastern District of Pennsylvania and the United States Department of Justice are now requesting information from Eli Lilly and Company, and Valeant Pharmaceuticals International, Inc. [read post]
7 Nov 2015, 2:36 pm
The United States Attorney’s Office for the Eastern District of Pennsylvania and the United States Department of Justice are now requesting information from Eli Lilly and Company, and Valeant Pharmaceuticals International, Inc. [read post]
16 Oct 2015, 1:56 pm
The MSN article notes that two pharmaceutical companies: Valeant Pharmaceuticals International and Turing Pharmaceuticals, described as among the “worst offenders” in so-called drug “price gouging” received formal requests from prosecutors investigating their drug pricing and other business practices. [read post]
1 Dec 2014, 6:05 am
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
1 Sep 2014, 4:00 am
-based Valeant Pharmaceuticals International Inc. for California-based Allergan Inc. offers Canadian observers a chance to see what hostile takeovers might look like when the target is located in the U.S…. [read post]
13 May 2014, 5:00 am
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
13 May 2014, 5:00 am
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
9 May 2014, 4:18 am
Bill Ackman’s Pershing Square recently announced it had purchased 10 percent beneficial ownership of Allergan in support of a bid–which had not yet been announced–by Canada’s Valeant Pharmaceuticals. [read post]
18 Jul 2012, 1:35 pm
See Valeant Pharmaceuticals International v. [read post]
11 Jul 2012, 9:50 pm
Valeant International (Barbados) SRL v. [read post]
26 Apr 2012, 9:18 pm
.; Valeant International (Barbados) SRL • Defendants: Watson Laboratories Inc. [read post]
